These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20348148)

  • 1. Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
    Yilmaz MI; Sonmez A; Saglam M; Yaman H; Cayci T; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Yenicesu M; Axelsson J
    Nephrol Dial Transplant; 2010 Oct; 25(10):3250-6. PubMed ID: 20348148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
    Yilmaz MI; Saglam M; Sonmez A; Caglar K; Cakir E; Kurt Y; Eyileten T; Tasar M; Acikel C; Oguz Y; Vural A; Yenicesu M
    Blood Purif; 2007; 25(4):327-35. PubMed ID: 17709915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.
    Eyileten T; Sonmez A; Saglam M; Cakir E; Caglar K; Oguz Y; Vural A; Yenicesu M; Yilmaz MI
    Nephrology (Carlton); 2010 Mar; 15(2):225-9. PubMed ID: 20470283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.
    Yilmaz MI; Axelsson J; Sonmez A; Carrero JJ; Saglam M; Eyileten T; Caglar K; Kirkpantur A; Celik T; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):535-41. PubMed ID: 19211665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy.
    Yilmaz MI; Sonmez A; Saglam M; Kurt YG; Unal HU; Karaman M; Gok M; Cetinkaya H; Eyileten T; Oguz Y; Vural A; Mallamaci F; Zoccali C
    Am J Nephrol; 2014; 40(3):208-14. PubMed ID: 25324042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
    Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL; Ekhlas A; Nguyen JM; Moranne O
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.
    Caglar K; Yilmaz MI; Sonmez A; Cakir E; Kaya A; Acikel C; Eyileten T; Yenicesu M; Oguz Y; Bilgi C; Oktenli C; Vural A; Zoccali C
    Kidney Int; 2006 Aug; 70(4):781-7. PubMed ID: 16820789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
    Yilmaz MI; Saglam M; Qureshi AR; Carrero JJ; Caglar K; Eyileten T; Sonmez A; Cakir E; Oguz Y; Vural A; Yenicesu M; Stenvinkel P; Lindholm B; Axelsson J
    Nephrol Dial Transplant; 2008 May; 23(5):1621-7. PubMed ID: 18175782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of ramipril in the treatment of diabetic nephropathy in normotensive children and adolescents].
    Sivous GI; Kasatkina EP; Samsonova LN; Voĭchik EA; Gerasimov NP
    Klin Med (Mosk); 1997; 75(12):52-4. PubMed ID: 9503815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.
    Yilmaz MI; Sonmez A; Saglam M; Qureshi AR; Carrero JJ; Caglar K; Eyileten T; Cakir E; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
    J Am Soc Nephrol; 2008 Feb; 19(2):388-95. PubMed ID: 18199801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
    Toto RD; Adams-Huet B; Fenves AZ; Mitchell HC; Mulcahy W; Smith RD
    Am J Kidney Dis; 1996 Dec; 28(6):832-40. PubMed ID: 8957034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U; Chaisuvannarat V
    J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.